Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Simon Kennon , Zhan Lim Added: 3 years ago
The main advantages of transcatheter aortic valve implantation (TAVI) over conventional aortic valve replacement (cAVR) surgery are the avoidance of sternotomy, heart lung bypass and prolonged procedure times. These advantages facilitate early mobilisation and discharge – important both clinically and in terms of resource utilisation. Balanced against this, TAVI is less predictable than cAVR –… View more
Author(s): Liesbeth Rosseel , Michael Rosseel , Brian G Hynes , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has emerged as a safe and effective strategy for the treatment of symptomatic and severe aortic valve stenosis (AS).1 The choice between a transcatheter or surgical approach is no longer dependant on the estimated surgical risk, but rather the institutional heart team’s assessment of medical comorbid illnesses and frailty, individual cardiac and… View more
Author(s): Antonio Greco , Davide Capodanno Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is a valuable treatment option for patients with severe symptomatic aortic stenosis.1 Its use is supported by the results of multiple randomised controlled trials (RCTs) exploring the entire surgical risk spectrum, including inoperable, high-risk, intermediate risk and low risk patients.2–8 TAVI is associated with a small but not negligible… View more
Author(s): Shu-I Lin , Mizuki Miura , Ana Paula Tagliari , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is now established as the standard treatment for symptomatic severe aortic stenosis (AS) in patients at high or prohibitive surgical risk, and the preferred treatment for those at intermediate risk.1 Based on recent trials in low-risk patients, the indications for TAVI are expanding towards the lower-risk classes, and the procedure has even been… View more
Author(s): Darren Mylotte , Ruben LJ Osnabrugge , Giuseppe Martucci , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has emerged as a safe and efficacious treatment in patients with symptomatic severe aortic stenosis (AS) at high- or excessive-risk for surgical aortic valve replacement.1,2 More recently, TAVI technology has been extended to treating high-risk patients with failing aortic or mitral surgical bioprosthetic valves, bicuspid aortic stenosis, pure aortic… View more
Author(s): Yusuke Watanabe , Ken Kozuma Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is evolving rapidly with an exponential growth in the number of procedures in worldwide.1,2 As worldwide experience with this modality increases, more and more patients are being offered this alternative to open surgery for the treatment of severe, symptomatic aortic stenosis (AS). Although this technique has reached relative maturity, further… View more
Author(s): Shu-I Lin , Mizuki Miura , Ana Paula Tagliari , et al Added: 3 years ago
In the article by Lin et al. entitled Intraventricular Conduction Disturbances After Transcatheter Aortic Valve Implantation (Interventional Cardiology Review 2020;15:e11. https://doi.org/10.15420/icr.2020.07), the following correction should be made. Author Ying-Hsian Lee should be spelled Ying-Hsiang Lee The authors and Interventional Cardiology Review apologise for this error. View more